MEDINDIA
English
हिन्दी
Español
français
中文
Email
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Ribociclib.
Alfentanil
The serum concentration of Alfentanil can be increased when it is combined with Ribociclib.
Alprazolam
The serum concentration of Alprazolam can be increased when it is combined with Ribociclib.
Amiodarone
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Amiodarone.
Anagrelide
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Anagrelide.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Ribociclib.
Anhydrous Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Ribociclib.
Apalutamide
The serum concentration of Ribociclib can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Aprepitant can be increased when it is combined with Ribociclib.
Arsenic Trioxide
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Arsenic trioxide.
Astemizole
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Astemizole.
Atazanavir
The serum concentration of Ribociclib can be increased when it is combined with Atazanavir.
Atorvastatin
The serum concentration of Atorvastatin can be increased when it is combined with Ribociclib.
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Ribociclib.
Azithromycin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Azithromycin.
Bepridil
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Bepridil.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Ribociclib.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Ribociclib.
Boceprevir
The serum concentration of Ribociclib can be increased when it is combined with Boceprevir.
Budesonide
The serum concentration of Budesonide can be increased when it is combined with Ribociclib.
Buspirone
The serum concentration of Buspirone can be increased when it is combined with Ribociclib.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Ribociclib.
Carbamazepine
The serum concentration of Ribociclib can be decreased when it is combined with Carbamazepine.
Ceritinib
The serum concentration of Ribociclib can be increased when it is combined with Ceritinib.
Chloroquine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Chloroquine.
Chlorpromazine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Chlorpromazine.
Cilostazol
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Cilostazol.
Ciprofloxacin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Ciprofloxacin.
Cisapride
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Cisapride.
Citalopram
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Citalopram.
Clarithromycin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Clarithromycin.
Cobicistat
The serum concentration of Ribociclib can be increased when it is combined with Cobicistat.
Cocaine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Cocaine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Ribociclib.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Ribociclib.
Curcumin
The serum concentration of Ribociclib can be increased when it is combined with Curcumin.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Ribociclib.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Ribociclib.
Darifenacin
The serum concentration of Darifenacin can be increased when it is combined with Ribociclib.
Darunavir
The serum concentration of Ribociclib can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Dasatinib can be increased when it is combined with Ribociclib.
Dasatinib Anhydrous
The serum concentration of Dasatinib can be increased when it is combined with Ribociclib.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Ribociclib.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Ribociclib.
Digoxin
Digoxin may decrease the cardiotoxic activities of Ribociclib.
Disopyramide
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Disopyramide.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Ribociclib.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Ribociclib.
Dofetilide
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Dofetilide.
Domperidone
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Domperidone.
Donepezil
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Donepezil.
Dronedarone
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Dronedarone.
Droperidol
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Droperidol.
Ebastine
The serum concentration of Ebastine can be increased when it is combined with Ribociclib.
Eletriptan
The serum concentration of Eletriptan can be increased when it is combined with Ribociclib.
Eliglustat
The serum concentration of Eliglustat can be increased when it is combined with Ribociclib.
Enzalutamide
The serum concentration of Ribociclib can be decreased when it is combined with Enzalutamide.
Eplerenone
The serum concentration of Eplerenone can be increased when it is combined with Ribociclib.
Erythromycin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Erythromycin.
Escitalopram
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Escitalopram.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Ribociclib.
Felodipine
The serum concentration of Felodipine can be increased when it is combined with Ribociclib.
Flecainide
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Flecainide.
Fluconazole
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Fluconazole.
Fosphenytoin
The serum concentration of Ribociclib can be decreased when it is combined with Fosphenytoin.
Gatifloxacin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Gatifloxacin.
Gatifloxacin Anhydrous
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Gatifloxacin.
Grepafloxacin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Grepafloxacin.
Halofantrine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Halofantrine.
Haloperidol
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Haloperidol.
Hypoxis hemerocallidea root extract
The serum concentration of Ribociclib can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Ribociclib.
Ibutilide
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Ibutilide.
Idelalisib
The serum concentration of Ribociclib can be increased when it is combined with Idelalisib.
Indinavir
The serum concentration of Ribociclib can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Ribociclib can be increased when it is combined with Indinavir.
Itraconazole
The serum concentration of Ribociclib can be increased when it is combined with Itraconazole.
Ketoconazole
The serum concentration of Ribociclib can be increased when it is combined with Ketoconazole.
Levofloxacin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Levofloxacin.
Levofloxacin Anhydrous
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Levofloxacin.
Levomethadyl
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Levomethadyl Acetate.
Lomitapide
The serum concentration of Lomitapide can be increased when it is combined with Ribociclib.
Lopinavir
The serum concentration of Ribociclib can be increased when it is combined with Lopinavir.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Ribociclib.
Lumacaftor
The serum concentration of Ribociclib can be decreased when it is combined with Lumacaftor.
Lurasidone
The serum concentration of Lurasidone can be increased when it is combined with Ribociclib.
Maraviroc
The serum concentration of Maraviroc can be increased when it is combined with Ribociclib.
Mesoridazine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Mesoridazine.
Methadone
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Methadone.
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Methotrimeprazine.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Ribociclib.
Midostaurin
The serum concentration of Ribociclib can be decreased when it is combined with Midostaurin.
Mitotane
The serum concentration of Ribociclib can be decreased when it is combined with Mitotane.
Moxifloxacin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Moxifloxacin.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Ribociclib.
Nefazodone
The serum concentration of Ribociclib can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Ribociclib can be increased when it is combined with Nelfinavir.
Nevirapine
The serum concentration of Ribociclib can be decreased when it is combined with Nevirapine.
Nisoldipine
The serum concentration of Nisoldipine can be increased when it is combined with Ribociclib.
Ondansetron
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Ondansetron.
Ouabain
Ouabain may decrease the cardiotoxic activities of Ribociclib.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Ribociclib.
Oxaliplatin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Oxaliplatin.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Ribociclib.
Papaverine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Papaverine.
Pentamidine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Pentamidine.
Pentobarbital
The serum concentration of Ribociclib can be decreased when it is combined with Pentobarbital.
Phenobarbital
The serum concentration of Ribociclib can be decreased when it is combined with Phenobarbital.
Phenytoin
The serum concentration of Ribociclib can be decreased when it is combined with Phenytoin.
Pimozide
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Pimozide.
Posaconazole
The serum concentration of Ribociclib can be increased when it is combined with Posaconazole.
Primidone
The serum concentration of Ribociclib can be decreased when it is combined with Primidone.
Probucol
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Probucol.
Procainamide
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Procainamide.
Propofol
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Propofol.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Ribociclib.
Quetiapine
The serum concentration of Quetiapine can be increased when it is combined with Ribociclib.
Quetiapine fumarate
The serum concentration of Quetiapine can be increased when it is combined with Ribociclib.
Quinidine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Quinidine.
Rifabutin
The serum concentration of Ribociclib can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Ribociclib can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Ribociclib can be decreased when it is combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Ribociclib.
Rivaroxaban
The serum concentration of Rivaroxaban can be increased when it is combined with Ribociclib.
Roxithromycin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Roxithromycin.
Saquinavir
The serum concentration of Ribociclib can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Ribociclib can be increased when it is combined with Saquinavir.
Sevoflurane
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Sevoflurane.
Sildenafil
The serum concentration of Sildenafil can be increased when it is combined with Ribociclib.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Ribociclib.
Sirolimus
The serum concentration of Sirolimus can be increased when it is combined with Ribociclib.
Sotalol
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Sotalol.
Sparfloxacin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Sparfloxacin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Ribociclib can be decreased when it is combined with St. John's Wort.
Sulpiride
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Sulpiride.
Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Ribociclib.
Tadalafil
The serum concentration of Tadalafil can be increased when it is combined with Ribociclib.
Telaprevir
The serum concentration of Ribociclib can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Ribociclib can be increased when it is combined with Telithromycin.
Terfenadine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Terfenadine.
Terlipressin
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Terlipressin.
Thioridazine
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Thioridazine.
Ticagrelor
The serum concentration of Ticagrelor can be increased when it is combined with Ribociclib.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Ribociclib.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Ribociclib.
Triazolam
The serum concentration of Triazolam can be increased when it is combined with Ribociclib.
Vandetanib
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Vandetanib.
Vardenafil
The serum concentration of Vardenafil can be increased when it is combined with Ribociclib.
Voriconazole
The serum concentration of Ribociclib can be increased when it is combined with Voriconazole.
